LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged analytics · clear

Patent Prosecution

Prosecution Poker with Appeal and Pre-Appeal Statistics (updated April 2019)

In my previous post , I looked at two metrics - allowance rate and actions per disposal - that I find useful in assessing an examiner and formulating a strategy for dealing with the examiner. In this post I will look at three more such metrics: (1)…

April 4, 2019·Patent Prosecution·6 min read
Patent Prosecution

Does Size Matter?

No, my site did not get overrun by the pharmaceutical pushers that like to submit "advice" in the comments section. The title is referring to entity size (i.e., undiscounted, small, or micro). This posts will compare the three entity types on…

March 20, 2019·Patent Prosecution·3 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.